MapLight Therapeutics, Inc. (MPLT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 327.23M | 324.67M | 245.31M | 73.2M | 98.26M | 114.6M | 183.89M | 0 |
| Cash & Short-Term Investments | 310.11M | 305.1M | 227.17M | 60.47M | 92.26M | 108.8M | 179.81M | 27.66M |
| Cash Only | 55.71M | 46.73M | 64.15M | 33.47M | 50.16M | 38.25M | 179.81M | 0 |
| Short-Term Investments | 254.41M | 258.37M | 163.02M | 27M | 42.11M | 70.54M | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 17.11M | 19.57M | 18.14M | 0 | 0 | 5.81M | 0 | -27.66M |
| Total Non-Current Assets | 91.56M | 154.84M | 11.92M | 10.92M | 13.3M | 22.31M | 8.68M | 0 |
| Property, Plant & Equipment | 6.23M | 6.58M | 6.57M | 6.9M | 7.18M | 7.56M | 6.36M | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 85.3M | 148.2M | 207K | 207K | 2.7M | 11.38M | 659K | 0 |
| Other Non-Current Assets | 36K | 59K | 5.14M | 3.81M | 3.42M | 3.37M | 1.67M | 0 |
| Total Assets | 418.79M | 479.51M | 257.22M | 84.12M | 111.57M | 136.92M | 192.57M | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - |
| Asset Growth % | 275.37% | 250.22% | - | - | -42.06% | - | - | - |
| Total Current Liabilities | 14.28M | 16.23M | 18.56M | 14.98M | 12.98M | 15.92M | 14.45M | 0 |
| Accounts Payable | 0 | 0 | 2.45M | 2.1M | 862K | 1.91M | 4.05M | 0 |
| Days Payables Outstanding | - | - | 1.54K | 991.63 | 751.99 | - | 10.09K | - |
| Short-Term Debt | 920K | 891K | 862K | 833K | 805K | 778K | 514K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 1.21M | 2.41M | 3.24M | 3.24M | 3.96M | 0 |
| Other Current Liabilities | 11.15M | 9.18M | 4M | 6.97M | 6.76M | 3.23M | 5.02M | 0 |
| Current Ratio | 22.91x | 20.01x | 13.22x | 4.89x | 7.57x | 7.20x | 12.72x | - |
| Quick Ratio | 22.91x | 20.01x | 13.22x | 4.89x | 7.57x | 7.20x | 12.72x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 4.67M | 4.91M | 5.14M | 5.37M | 5.59M | 314.62M | 5.29M | -20.87M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 4.67M | 4.91M | 5.14M | 5.37M | 5.59M | 5.8M | 5.29M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | -1K | 0 | 0 | 308.82M | 0 | -20.87M |
| Total Liabilities | 18.95M | 21.14M | 23.7M | 20.36M | 18.57M | 330.54M | 19.75M | -20.87M |
| Total Debt | 5.59M | 5.8M | 6.01M | 6.21M | 6.39M | 6.58M | 5.81M | 0 |
| Net Debt | -50.12M | -40.93M | -58.14M | -27.26M | -43.76M | -31.67M | -174M | 0 |
| Debt / Equity | 0.01x | 0.01x | 0.03x | 0.10x | 0.07x | - | 0.03x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - |
| Total Equity | 399.83M | 458.37M | 233.52M | 63.76M | 93M | -193.63M | 172.83M | 20.87M |
| Equity Growth % | 329.95% | 336.73% | - | - | -46.19% | - | 728.11% | - |
| Book Value per Share | 8.83 | 10.41 | 5.64 | 1.54 | 2.24 | -4.67 | 4.17 | 0.50 |
| Total Shareholders' Equity | 399.83M | 458.37M | 233.52M | 63.76M | 93M | 115.19M | 172.83M | 20.87M |
| Common Stock | 5K | 5K | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -421.19M | -360.52M | -280.97M | -251.55M | -221.71M | -199.37M | -140.72M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -883K | -228K | 46K | 50K | 85K | 163K | 0 | -62.96M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |